You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Non-resectable non-small cell lung cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stage II-IIIB(N2) NSCLC Trial in Shanghai (TQB2450, Carboplatin, Pemetrexed)

Not yet recruiting
  • Stage II-IIIB(N2) Non-small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Oct 26, 2023

NSCLC Trial in Beijing

Recruiting
  • NSCLC
    • Beijing, China
      Yuyan Wang
    Oct 10, 2023

    NSCLC With Mutation in Epidermal Growth Factor Receptor Trial (Osimertinib, Aspirin)

    Not yet recruiting
    • Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
    • (no location specified)
    Aug 27, 2023

    Lung Cancer Trial (Sacituzumab Govitecan, Pembrolizumab)

    Not yet recruiting
    • Lung Cancer
    • (no location specified)
    Sep 20, 2023

    NSCLC(NSCLC) Trial in Jinan (WX-0593 Tablets)

    Not yet recruiting
    • Non-Small Cell Lung Cancer(NSCLC)
    • WX-0593 Tablets
    • Jinan, Shandong, China
      Shandong Cancer Hospital and Institute
    Mar 1, 2023

    Resectable Stage II-IIIB Driver Gene-negative Non-small Cell

    Not yet recruiting
    • NSCLC
      • Changsha, Hunan, China
        Hunan Cancer Hospital
      Aug 6, 2023

      Stage III NSCLC Trial (Toripalimab, JS004, Pemetrexed)

      Not yet recruiting
      • Stage III Non-small Cell Lung Cancer
      • (no location specified)
      Jun 3, 2023

      Non Small Cell Lung Cancer, Non-small Cell Carcinoma Trial in Belgium (Physical activity tele coaching program)

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • Non-small Cell Carcinoma
      • Physical activity tele coaching program
      • Genk, Limburg, Belgium
      • +5 more
      Sep 28, 2023

      NSCLC, Neoadjuvant Therapy Trial in Hangzhou (Serplulimab and neoadjuvant therapy, surgical resection of lung cancer)

      Recruiting
      • NSCLC
      • Neoadjuvant Therapy
      • Serplulimab and neoadjuvant therapy
      • surgical resection of lung cancer
      • Hangzhou, China
        2nd Affiliated Hospital, School of Medicine, Zhejiang University
      May 22, 2023

      Non Squamous Non Small Cell Lung Cancer, EGFR Positive NSCLC Trial (Toripalimab plus Chemotherapy)

      Not yet recruiting
      • Non Squamous Non Small Cell Lung Cancer
      • EGFR Positive Non-small Cell Lung Cancer
      • Toripalimab plus Chemotherapy
      • (no location specified)
      Jul 28, 2023

      NSCLC Trial (JDQ443)

      Not yet recruiting
      • NSCLC
      • (no location specified)
      Feb 2, 2023

      Non Small Cell Lung Cancer Trial (Tislelizumab, Ociperlimab, LBL-007)

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • (no location specified)
      Jan 30, 2023

      NSCLC Trial (Dupilumab, Cemiplimab)

      Not yet recruiting
      • Non-Small Cell Lung Cancer
      • Dupilumab
      • Cemiplimab
      • (no location specified)
      Oct 12, 2023

      Resectable Lung Non-Small Cell Carcinoma Trial in Atlanta (procedure, radiation, other)

      Not yet recruiting
      • Resectable Lung Non-Small Cell Carcinoma
      • Biospecimen Collection
      • +2 more
      • Atlanta, Georgia
        Emory University Hospital/Winship Cancer Institute
      Aug 22, 2023

      NSCLC Trial (Durvalumab)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • (no location specified)
      Jun 22, 2023

      Non Small Cell Lung Cancer Trial in Beijing (Ensartinib)

      Recruiting
      • Non Small Cell Lung Cancer
      • Beijing, Beijing, China
      • +1 more
      Aug 17, 2022

      Huaier Granules in Postoperative Adjuvant Therapy for Non-small

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • Huaier granule
      • Control
      • Shenyang, Liaoning, China
        Liaoning Cancer Hospital & Institute
      Oct 27, 2023

      Resectable Early-stage Non-small Cell Lung Cancer

      Completed
      • Non-small Cell Lung Cancer
        • Alexandria, Egypt
        • +3 more
        Nov 21, 2022

        Non Small Cell Lung Cancer, Stage I Lung Cancer, Stage Ib Lung Carcinoma Trial in Winston-Salem (Vitamin A Compound, Therapeutic

        Active, not recruiting
        • Non Small Cell Lung Cancer
        • +5 more
        • Vitamin A Compound
        • Therapeutic Conventional Surgery
        • Winston-Salem, North Carolina
          Wake Forest Baptist Comprehensive Cancer Center
        Jan 5, 2023

        NSCLC Trial in Chongqing (procedure, drug, radiation)

        Not yet recruiting
        • Carcinoma, Non-Small-Cell Lung
        • bronchial artery interventional therapy
        • +3 more
        • Chongqing, Chongqing, China
          Daping Hospital, Third Military Medical University
        May 27, 2023

        NSCLC, Stage II-IIIA, Immunotherapy Trial in Shanghai (Serplulimab and Chemotherapy)

        Recruiting
        • Non-small Cell Lung Cancer
        • +3 more
        • Serplulimab and Chemotherapy
        • Shanghai, Shanghai, China
          Fudan University Shanghai Cancer Center
        Mar 27, 2023

        NSCLC Trial (Furmonertinib)

        Not yet recruiting
        • Non-Small Cell Lung Cancer
        • (no location specified)
        Aug 10, 2023

        Resectable Stage IIA to IIIB NSCLC Trial (Nivolumab, (8gy x 3), Platinum Doublet)

        Not yet recruiting
        • Resectable Stage IIA to IIIB Non-small Cell Lung Cancer
        • (no location specified)
        Aug 10, 2022

        Non Small Cell Lung Cancer, Stage III Non-small-cell Lung Cancer Trial in United States (device, drug, radiation, procedure)

        Active, not recruiting
        • Non Small Cell Lung Cancer
        • Stage III Non-small-cell Lung Cancer
        • Durvalumab
        • +4 more
        • Chicago, Illinois
        • +3 more
        Jan 18, 2023

        Stage IIIA NSCLC Trial in Cleveland (Cisplatin, Etoposide, Pembrolizumab)

        Terminated
        • Stage IIIA Non-Small Cell Lung Cancer
        • Cleveland, Ohio
          Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
        Dec 15, 2022